Accuray Incorporated (ARAY) is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in fourth-quarter fiscal 2024 performance and potential in the Precision Treatment Planning System (TPS) and Radiosurgery Market, is expected to contribute further. However, reimbursement uncertainties and stiff competition are concerning.This Zacks Rank #3 (Hold) company has lost 23% in the year-to-date period against 9.2% ...

Accuray Incorporated (ARAY) recently announced that Japan-based Gifu Prefectural General Medical Center became the first hospital in the country to treat patients with surface-guided radiation therapy (SGRT) using its Radixact Radiation Delivery System and VitalHold (ARAY’s joint solution in partnership with C-Rad) package. The technology is expected to play a crucial role in the hospital's plan to expand patient access to high-precision radiation therapy treatments.Per Accuray, high-resolution cameras cont ...

MADISON, Wis., Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Chalke will serve as the interim CEO during Ms. Winter's absence. To ensure that Mr. Chalke and the organization have the necessary support, the company has formed an ...

Accuray Incorporated (ARAY) has announced that its innovative CT-guided helical radiotherapy system, Accuray Helix, has received the CE Mark, signaling its readiness for deployment in global markets. Designed to meet the needs of emerging regions where access to advanced cancer care is limited, the Accuray Helix system offers a cost-effective solution for delivering high-performance, precise radiation treatments. Radiotherapy is an essential part of cancer treatment, effective for both localized and advance ...

Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priorityDrives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systemsMADISON, Wis., Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark for Accuray Helix™, a CT-guided helical radiotherapy system designed to provide high-performance and high ...

baranozdemir Despite a well-received fiscal fourth quarter report that sent the shares up more than 50%, the reality is that Accuray (NASDAQ:ARAY) continues to struggle to show any real progress. This recently concluded fiscal year marked the third straight year of revenue in the $425M-$450M area, and the company has grown revenue by less than 2% a year over the past decade. While profitability has actually improved, the reality is that the shares have lost 25% of their value over the past five years (while ...

Accuray Incorporated (ARAY) and Halifax Health announced a breakthrough in cancer treatment at the Charles L. and Miki N. Grant Cancer Center for Hope in Port Orange, FL. The center's medical team became the first in the United States to treat cancer patients using Accuray’s Radixact System with VitalHold technology. This innovative system is designed to enhance the precision of radiation therapy by improving patient positioning and monitoring throughout the treatment process, offering a new standard of car ...

Accuray Incorporated (ARAY) reported fourth-quarter fiscal 2024 earnings per share (EPS) of 3 cents against the year-ago period’s reported loss of 3 cents per share. The bottom line missed the Zacks Consensus Estimate of 4 cents.Revenues in DetailAccuray registered quarterly revenues of $134.3 million, up 13.5% year over year. The figure beat the Zacks Consensus Estimate by 9.4%.The overall top-line growth was driven by higher product sales, partially offset by lower service revenues.At constant exchange ra ...

Accuray Incorporated (NASDAQ:ARAY) Q4 2024 Earnings Call Transcript August 14, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pervaiz - CFO Conference Call Participants Young Li - Jefferies Marie Thibault - BTIG Brooks O'Neil - Lake Street Capital Markets Jason Wittes - Roth Capital Operator Good day, and welcome to the Accuray Fscal 2024 Fourth Quarter Financial Results Call. All participants will be in listen-only mode. [Operator Instru ...

Q4'FY24 Earnings Call Supplemental Presentation August 14, 2024 Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in ...